Literature DB >> 14970018

Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: tumor recurrence versus radiation injury.

Patrick A Hein1, Clifford J Eskey, Jeffrey F Dunn, Eugen B Hug.   

Abstract

BACKGROUND AND
PURPOSE: Diffusion-weighted (DW) MR imaging is a means to characterize and differentiate morphologic features, including edema, necrosis, and tumor tissue, by measuring differences in apparent diffusion coefficient (ADC). We hypothesized that DW imaging has the potential to differentiate recurrent or progressive tumor growth from treatment-induced damage to brain parenchyma in high-grade gliomas after radiation therapy.
METHODS: We retrospectively reviewed follow-up conventional and DW MR images obtained starting 1 month after completion of radiation treatment with or without chemotherapy for histologically proved high-grade gliomas. Eighteen patients with areas of abnormal enhancing tissue were identified. ADC maps were calculated from echo-planar DW images, and mean ADC values and ADC ratios (ADC of enhancing lesion to ADC of contralateral white matter) were compared with final diagnosis. Recurrence was established by histologic examination or by clinical course and a combination of imaging studies.
RESULTS: Recurrence and nonrecurrence could be differentiated by using mean ADC values and ADC ratios. ADC ratios in the recurrence group showed significantly lower values (mean +/- SD, 1.43 +/- 0.11) than those of the nonrecurrence group (1.82 +/- 0.07, P <.001). Mean ADCs of the recurrent tumors (mean +/- SD, 1.18 +/- 0.13 x 10(-3) mm/s(2)) were significantly lower than those of the nonrecurrence group (1.40 +/- 0.17 x 10(-3) mm/s(2), P <.006).
CONCLUSION: Assessment of ADC ratios of enhancing regions in the follow-up of treated high-grade gliomas is useful in differentiating radiation effects from tumor recurrence or progression.

Entities:  

Mesh:

Year:  2004        PMID: 14970018      PMCID: PMC7974622     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  28 in total

1.  Differentiation of radiation necrosis from tumor progression using proton magnetic resonance spectroscopy.

Authors:  H P Schlemmer; P Bachert; M Henze; R Buslei; K K Herfarth; J Debus; G van Kaick
Journal:  Neuroradiology       Date:  2002-03       Impact factor: 2.804

2.  The role of diffusion-weighted imaging in patients with brain tumors.

Authors:  K Kono; Y Inoue; K Nakayama; M Shakudo; M Morino; K Ohata; K Wakasa; R Yamada
Journal:  AJNR Am J Neuroradiol       Date:  2001 Jun-Jul       Impact factor: 3.825

3.  Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery.

Authors:  E E Graves; S J Nelson; D B Vigneron; L Verhey; M McDermott; D Larson; S Chang; M D Prados; W P Dillon
Journal:  AJNR Am J Neuroradiol       Date:  2001-04       Impact factor: 3.825

4.  Late temporal lobe necrosis in patients with nasopharyngeal carcinoma: evaluation with combined multi-section diffusion weighted and perfusion weighted MR imaging.

Authors:  E Y Tsui; J H Chan; R G Ramsey; T W Leung; Y K Cheung; S H Luk; K F Lai; K P Wong; D Fong; M K Yuen
Journal:  Eur J Radiol       Date:  2001-09       Impact factor: 3.528

5.  Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy.

Authors:  H P Schlemmer; P Bachert; K K Herfarth; I Zuna; J Debus; G van Kaick
Journal:  AJNR Am J Neuroradiol       Date:  2001-08       Impact factor: 3.825

6.  Diffusion MR imaging in glioma: does it have any role in the pre-operation determination of grading of glioma?

Authors:  W W M Lam; W S Poon; C Metreweli
Journal:  Clin Radiol       Date:  2002-03       Impact factor: 2.350

7.  Diffusion-weighted MR imaging of intracerebral masses: comparison with conventional MR imaging and histologic findings.

Authors:  T W Stadnik; C Chaskis; A Michotte; W M Shabana; K van Rompaey; R Luypaert; L Budinsky; V Jellus; M Osteaux
Journal:  AJNR Am J Neuroradiol       Date:  2001-05       Impact factor: 3.825

8.  Clinical usefulness of 11C-MET PET and 201T1 SPECT for differentiation of recurrent glioma from radiation necrosis.

Authors:  Y Sonoda; T Kumabe; T Takahashi; R Shirane; T Yoshimoto
Journal:  Neurol Med Chir (Tokyo)       Date:  1998-06       Impact factor: 1.742

9.  Assessing tissue viability with MR diffusion and perfusion imaging.

Authors:  Pamela W Schaefer; Yelda Ozsunar; Julian He; Leena M Hamberg; George J Hunter; A Gregory Sorensen; Walter J Koroshetz; R Gilberto Gonzalez
Journal:  AJNR Am J Neuroradiol       Date:  2003-03       Impact factor: 3.825

10.  Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue.

Authors:  T Sugahara; Y Korogi; S Tomiguchi; Y Shigematsu; I Ikushima; T Kira; L Liang; Y Ushio; M Takahashi
Journal:  AJNR Am J Neuroradiol       Date:  2000-05       Impact factor: 4.966

View more
  124 in total

1.  Support vector machine multiparametric MRI identification of pseudoprogression from tumor recurrence in patients with resected glioblastoma.

Authors:  Xintao Hu; Kelvin K Wong; Geoffrey S Young; Lei Guo; Stephen T Wong
Journal:  J Magn Reson Imaging       Date:  2011-02       Impact factor: 4.813

2.  Development of a novel animal model to differentiate radiation necrosis from tumor recurrence.

Authors:  Sanath Kumar; Ali S Arbab; Rajan Jain; Jinkoo Kim; Ana C deCarvalho; Adarsh Shankar; Tom Mikkelsen; Stephen L Brown
Journal:  J Neurooncol       Date:  2012-03-10       Impact factor: 4.130

Review 3.  Clinical applications of imaging biomarkers. Part 3. The neuro-oncologist's perspective.

Authors:  A Shenoy
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

Review 4.  Applications of molecular imaging.

Authors:  Craig J Galbán; Stefanie Galbán; Marcian E Van Dort; Gary D Luker; Mahaveer S Bhojani; Alnawaz Rehemtulla; Brian D Ross
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

Review 5.  Treatment induced necrosis versus recurrent/progressing brain tumor: going beyond the boundaries of conventional morphologic imaging.

Authors:  Rajan Jain; Jayant Narang; Pia M Sundgren; David Hearshen; Sona Saksena; Jack P Rock; Jorge Gutierrez; Tom Mikkelsen
Journal:  J Neurooncol       Date:  2010-02-24       Impact factor: 4.130

6.  Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis.

Authors:  Mark E Mullins; Glenn D Barest; Pamela W Schaefer; Fred H Hochberg; R Gilberto Gonzalez; Michael H Lev
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

7.  Diagnostic Accuracy of Centrally Restricted Diffusion in the Differentiation of Treatment-Related Necrosis from Tumor Recurrence in High-Grade Gliomas.

Authors:  N Zakhari; M S Taccone; C Torres; S Chakraborty; J Sinclair; J Woulfe; G H Jansen; T B Nguyen
Journal:  AJNR Am J Neuroradiol       Date:  2017-12-07       Impact factor: 3.825

Review 8.  Treatment-related changes in glioblastoma: a review on the controversies in response assessment criteria and the concepts of true progression, pseudoprogression, pseudoresponse and radionecrosis.

Authors:  P D Delgado-López; E Riñones-Mena; E M Corrales-García
Journal:  Clin Transl Oncol       Date:  2017-12-07       Impact factor: 3.405

Review 9.  An Update on the Approach to the Imaging of Brain Tumors.

Authors:  Katherine M Mullen; Raymond Y Huang
Journal:  Curr Neurol Neurosci Rep       Date:  2017-07       Impact factor: 5.081

10.  Evaluation of pseudoprogression in patients with glioblastoma multiforme using dynamic magnetic resonance imaging with ferumoxytol calls RANO criteria into question.

Authors:  Morad Nasseri; Seymur Gahramanov; Joao Prola Netto; Rongwei Fu; Leslie L Muldoon; Csanad Varallyay; Bronwyn E Hamilton; Edward A Neuwelt
Journal:  Neuro Oncol       Date:  2014-02-11       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.